A detailed history of Citigroup Inc transactions in Beyond Spring Inc. stock. As of the latest transaction made, Citigroup Inc holds 454,250 shares of BYSI stock, worth $890,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
454,250
Holding current value
$890,330
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$1.76 - $3.6 $799,480 - $1.64 Million
454,250 New
454,250 $1.09 Million
Q3 2022

Nov 10, 2022

SELL
$0.97 - $1.81 $717 - $1,339
-740 Reduced 9.79%
6,815 $7,000
Q2 2022

Aug 10, 2022

SELL
$1.13 - $2.66 $75 - $178
-67 Reduced 0.88%
7,555 $11,000
Q1 2022

May 12, 2022

BUY
$1.68 - $5.01 $3,533 - $10,536
2,103 Added 38.1%
7,622 $17,000
Q4 2021

Feb 10, 2022

BUY
$4.02 - $16.84 $11,911 - $49,896
2,963 Added 115.92%
5,519 $25,000
Q3 2021

Nov 10, 2021

BUY
$9.26 - $31.31 $23,668 - $80,028
2,556 New
2,556 $40,000

Others Institutions Holding BYSI

About BeyondSpring Inc.


  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $76.3M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.